Search results

The mining industry is set to benefit from a new Australian capability that uses a nuclear scanning technique to detect the presence of precious metals and strategic minerals in a core sample.

ANSTO provides a range of capabilities using neutrons, X-rays and infrared radiation to study the solids, liquids and gases that might be found in materials in our solar system and beyond.

Australia and Sri Lanks signs new partnership to fight chronic kidney disease.

Congress marks watershed moment for nuclear medicine and ANSTO

See details of previously published customer updates from our Health products team. 

ANSTO has put together a robust multidisciplinary approach to understanding the impacts of nanomaterials, investigating a common food additive, E171 titanium dioxide, used primarily as a colouring agent in everyday foods. 

New international limits on the cadmium content of cacao products have spurred research to discover how cadmium accumulates in cacao beans, and the effects of processing.

Project Bright, the construction of eight new beamlines at ANSTO’s Australian Synchrotron has reached a milestone by achieving ‘First Light’ for the new micro-computed tomography (MCT) beamline in late NovembeR.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.

At ANSTO we understand that diverse teams produce better outcomes – and we value the merit that a diverse perspective can bring to the quality and outcomes of our work, and the way we get the job done.